1. 1448PPatterns of recurrence to Osimertinib in T790m positive NSCLC: A Swiss cohort study. (23rd October 2018) Authors: Schmid, S; Klingbiel, D; Aeppli, S; Britschgi, C; Gautschi, O; Pless, M; Rothschild, S I; Wannesson De Nicola, L; Janthur, W-D; Foerbs, D; Demmer, I; Jochum, W; Früh, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Compliance with antibiotic prophylaxis guidelines in a university hospital's neurosurgical unit: a 7-year follow-up. Issue 1 (December 2015) Authors: Agostinho, A; Olearo, F; Delannoy, D; Fouchard-Chavatte, F; Goascoz, M-C; Ares, M; Cabrilo, I; Gautschi, O; Tessitore, E; Bijlenga, P; Czarnetzki, C; Lysakowski, C; Schaller, K; Harbarth, S Journal: Antimicrobial resistance & infection control Issue: Volume 4:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. (24th May 2019) Authors: Mazieres, J; Drilon, A; Lusque, A; Mhanna, L; Cortot, A B; Mezquita, L; Thai, A A; Mascaux, C; Couraud, S; Veillon, R; Van den Heuvel, M; Neal, J; Peled, N; Früh, M; Ng, T L; Gounant, V; Popat, S; Diebold, J; Sabari, J; Zhu, V W Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗